Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Evaluating center-specific long-term outcomes through differences in mean survival time: Analysis of national kidney transplant data.

He K, Ashby VB, Schaubel DE.

Stat Med. 2019 Jan 4. doi: 10.1002/sim.8076. [Epub ahead of print]

PMID:
30609113
2.

Reevaluation of the Kidney Donor Risk Index (KDRI).

Zhong Y, Schaubel DE, Kalbfleisch JD, Ashby VB, Rao PS, Sung RS.

Transplantation. 2018 Nov 16. doi: 10.1097/TP.0000000000002498. [Epub ahead of print]

PMID:
30451742
3.

Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States.

Siontis KC, Zhang X, Eckard A, Bhave N, Schaubel DE, He K, Tilea A, Stack AG, Balkrishnan R, Yao X, Noseworthy PA, Shah ND, Saran R, Nallamothu BK.

Circulation. 2018 Oct 9;138(15):1519-1529. doi: 10.1161/CIRCULATIONAHA.118.035418. Erratum in: Circulation. 2018 Oct 9;138(15):e425. Circulation. 2018 Oct 9;138(15):e424.

PMID:
29954737
4.

Semiparametric temporal process regression of survival-out-of-hospital.

Zhan T, Schaubel DE.

Lifetime Data Anal. 2018 May 23. doi: 10.1007/s10985-018-9433-8. [Epub ahead of print]

PMID:
29796979
5.

Multicenter Study of Staging and Therapeutic Predictors of Hepatocellular Carcinoma Recurrence Following Transplantation.

Welling TH, Eddinger K, Carrier K, Zhu D, Kleaveland T, Moore DE, Schaubel DE, Abt PL.

Liver Transpl. 2018 Sep;24(9):1233-1242. doi: 10.1002/lt.25194.

PMID:
29729113
6.

Statistical Methods in Organ Failure and Transplantation.

Schaubel DE.

Stat Biosci. 2017 Dec;9(2):317-319. doi: 10.1007/s12561-017-9207-y. Epub 2017 Nov 27. No abstract available.

7.

Estimating the effect of a rare time-dependent treatment on the recurrent event rate.

Smith AR, Zhu D, Goodrich NP, Merion RM, Schaubel DE.

Stat Med. 2018 May 30;37(12):1986-1996. doi: 10.1002/sim.7626. Epub 2018 Feb 26.

PMID:
29479838
8.

US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Saran R, Robinson B, Abbott KC, Agodoa LYC, Bhave N, Bragg-Gresham J, Balkrishnan R, Dietrich X, Eckard A, Eggers PW, Gaipov A, Gillen D, Gipson D, Hailpern SM, Hall YN, Han Y, He K, Herman W, Heung M, Hirth RA, Hutton D, Jacobsen SJ, Jin Y, Kalantar-Zadeh K, Kapke A, Kovesdy CP, Lavallee D, Leslie J, McCullough K, Modi Z, Molnar MZ, Montez-Rath M, Moradi H, Morgenstern H, Mukhopadhyay P, Nallamothu B, Nguyen DV, Norris KC, O'Hare AM, Obi Y, Park C, Pearson J, Pisoni R, Potukuchi PK, Rao P, Repeck K, Rhee CM, Schrager J, Schaubel DE, Selewski DT, Shaw SF, Shi JM, Shieu M, Sim JJ, Soohoo M, Steffick D, Streja E, Sumida K, Tamura MK, Tilea A, Tong L, Wang D, Wang M, Woodside KJ, Xin X, Yin M, You AS, Zhou H, Shahinian V.

Am J Kidney Dis. 2018 Mar;71(3S1):A7. doi: 10.1053/j.ajkd.2018.01.002. No abstract available. Erratum in: Am J Kidney Dis. 2018 Apr;71(4):501.

PMID:
29477157
9.

Arteriovenous Fistula Maturation in Prevalent Hemodialysis Patients in the United States: A National Study.

Woodside KJ, Bell S, Mukhopadhyay P, Repeck KJ, Robinson IT, Eckard AR, Dasmunshi S, Plattner BW, Pearson J, Schaubel DE, Pisoni RL, Saran R.

Am J Kidney Dis. 2018 Jun;71(6):793-801. doi: 10.1053/j.ajkd.2017.11.020. Epub 2018 Feb 9. Erratum in: Am J Kidney Dis. 2018 Aug;72(2):314.

PMID:
29429750
10.

Tobit regression for modeling mean survival time using data subject to multiple sources of censoring.

Gong Q, Schaubel DE.

Pharm Stat. 2018 Mar;17(2):117-125. doi: 10.1002/pst.1844. Epub 2018 Jan 22.

PMID:
29359427
11.

Methods for Contrasting Gap Time Hazard Functions: Application to Repeat Liver Transplantation.

Shu X, Schaubel DE.

Stat Biosci. 2017 Dec;9(2):470-488. doi: 10.1007/s12561-016-9168-6. Epub 2016 Sep 26.

12.

Special issue dedicated to Jack Kalbfleisch.

Schaubel DE, Nan B.

Lifetime Data Anal. 2018 Jan;24(1):1-2. doi: 10.1007/s10985-017-9416-1. No abstract available.

13.

Impact of screening for metabolic syndrome on the evaluation of obese living kidney donors.

Marcusa DP, Schaubel DE, Woodside KJ, Sung RS.

Am J Surg. 2018 Jan;215(1):144-150. doi: 10.1016/j.amjsurg.2017.08.019. Epub 2017 Sep 1.

PMID:
28882358
14.

A C-index for recurrent event data: Application to hospitalizations among dialysis patients.

Kim S, Schaubel DE, McCullough KP.

Biometrics. 2018 Jun;74(2):734-743. doi: 10.1111/biom.12761. Epub 2017 Aug 3.

PMID:
28771674
15.

Initiation of Sevelamer and Mortality among Hemodialysis Patients Treated with Calcium-Based Phosphate Binders.

Komaba H, Wang M, Taniguchi M, Yamamoto S, Nomura T, Schaubel DE, Smith AR, Zee J, Karaboyas A, Bieber B, Fukagawa M, Tentori F.

Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1489-1497. doi: 10.2215/CJN.13091216. Epub 2017 Jul 19.

16.

National assessment of early hospitalization after liver transplantation: Risk factors and association with patient survival.

Sharma P, Goodrich NP, Schaubel DE, Smith AR, Merion RM.

Liver Transpl. 2017 Sep;23(9):1143-1152. doi: 10.1002/lt.24813.

17.

Evaluating center performance in the competing risks setting: Application to outcomes of wait-listed end-stage renal disease patients.

Dharmarajan SH, Schaubel DE, Saran R.

Biometrics. 2018 Mar;74(1):289-299. doi: 10.1111/biom.12739. Epub 2017 Jul 6.

PMID:
28682445
18.

US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Saran R, Robinson B, Abbott KC, Agodoa LY, Albertus P, Ayanian J, Balkrishnan R, Bragg-Gresham J, Cao J, Chen JL, Cope E, Dharmarajan S, Dietrich X, Eckard A, Eggers PW, Gaber C, Gillen D, Gipson D, Gu H, Hailpern SM, Hall YN, Han Y, He K, Hebert H, Helmuth M, Herman W, Heung M, Hutton D, Jacobsen SJ, Ji N, Jin Y, Kalantar-Zadeh K, Kapke A, Katz R, Kovesdy CP, Kurtz V, Lavalee D, Li Y, Lu Y, McCullough K, Molnar MZ, Montez-Rath M, Morgenstern H, Mu Q, Mukhopadhyay P, Nallamothu B, Nguyen DV, Norris KC, O'Hare AM, Obi Y, Pearson J, Pisoni R, Plattner B, Port FK, Potukuchi P, Rao P, Ratkowiak K, Ravel V, Ray D, Rhee CM, Schaubel DE, Selewski DT, Shaw S, Shi J, Shieu M, Sim JJ, Song P, Soohoo M, Steffick D, Streja E, Tamura MK, Tentori F, Tilea A, Tong L, Turf M, Wang D, Wang M, Woodside K, Wyncott A, Xin X, Zang W, Zepel L, Zhang S, Zho H, Hirth RA, Shahinian V.

Am J Kidney Dis. 2017 Mar;69(3 Suppl 1):A7-A8. doi: 10.1053/j.ajkd.2016.12.004. Review. No abstract available. Erratum in: Am J Kidney Dis. 2017 May;69(5):712.

PMID:
28236831
19.

Modeling restricted mean survival time under general censoring mechanisms.

Wang X, Schaubel DE.

Lifetime Data Anal. 2018 Jan;24(1):176-199. doi: 10.1007/s10985-017-9391-6. Epub 2017 Feb 21.

20.

National Assessment of Hospitalization Rates for Incident End-Stage Renal Disease After Liver Transplantation.

Goodrich NP, Schaubel DE, Smith AR, Merion RM, Sharma P.

Transplantation. 2016 Oct;100(10):2115-21. doi: 10.1097/TP.0000000000001348.

21.

Estimating the average treatment effect on survival based on observational data and using partly conditional modeling.

Gong Q, Schaubel DE.

Biometrics. 2017 Mar;73(1):134-144. doi: 10.1111/biom.12542. Epub 2016 May 18.

22.

US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Saran R, Li Y, Robinson B, Abbott KC, Agodoa LY, Ayanian J, Bragg-Gresham J, Balkrishnan R, Chen JL, Cope E, Eggers PW, Gillen D, Gipson D, Hailpern SM, Hall YN, He K, Herman W, Heung M, Hirth RA, Hutton D, Jacobsen SJ, Kalantar-Zadeh K, Kovesdy CP, Lu Y, Molnar MZ, Morgenstern H, Nallamothu B, Nguyen DV, O'Hare AM, Plattner B, Pisoni R, Port FK, Rao P, Rhee CM, Sakhuja A, Schaubel DE, Selewski DT, Shahinian V, Sim JJ, Song P, Streja E, Kurella Tamura M, Tentori F, White S, Woodside K, Hirth RA.

Am J Kidney Dis. 2016 Mar;67(3 Suppl 1):Svii, S1-305. doi: 10.1053/j.ajkd.2015.12.014. Review. No abstract available.

PMID:
26925525
23.

Semiparametric Contrasts of Cumulative Pre-Treatment Mortality in the Presence of Dependent Censoring.

Gong Q, Schaubel DE.

Stat Biosci. 2015 Oct 1;7(2):245-261. Epub 2014 Jul 2.

24.

Semiparametric methods to contrast gap time survival functions: Application to repeat kidney transplantation.

Shu X, Schaubel DE.

Biometrics. 2016 Jun;72(2):525-34. doi: 10.1111/biom.12427. Epub 2015 Oct 26.

25.

A Propensity Score Analysis of the Impact of Invasive Intracranial Pressure Monitoring on Outcomes after Severe Traumatic Brain Injury.

Agrawal D, Raghavendran K, Schaubel DE, Mishra MC, Rajajee V.

J Neurotrauma. 2016 May 1;33(9):853-8. doi: 10.1089/neu.2015.4015. Epub 2015 Oct 8.

26.

Time-dependent prognostic score matching for recurrent event analysis to evaluate a treatment assigned during follow-up.

Smith AR, Schaubel DE.

Biometrics. 2015 Dec;71(4):950-9. doi: 10.1111/biom.12361. Epub 2015 Aug 21.

27.

US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Saran R, Li Y, Robinson B, Ayanian J, Balkrishnan R, Bragg-Gresham J, Chen JT, Cope E, Gipson D, He K, Herman W, Heung M, Hirth RA, Jacobsen SS, Kalantar-Zadeh K, Kovesdy CP, Leichtman AB, Lu Y, Molnar MZ, Morgenstern H, Nallamothu B, O'Hare AM, Pisoni R, Plattner B, Port FK, Rao P, Rhee CM, Schaubel DE, Selewski DT, Shahinian V, Sim JJ, Song P, Streja E, Kurella Tamura M, Tentori F, Eggers PW, Agodoa LY, Abbott KC.

Am J Kidney Dis. 2015 Jul;66(1 Suppl 1):Svii, S1-305. doi: 10.1053/j.ajkd.2015.05.001. No abstract available. Erratum in: Am J Kidney Dis. 2015 Sep;66(3):545.

PMID:
26111994
28.

A Perspective on the Scientific Registry of Transplant Recipients' Migration to Bayesian Methods.

Kalbfleisch JD, Schaubel DE.

Am J Transplant. 2015 Aug;15(8):2271-2. doi: 10.1111/ajt.13354. Epub 2015 Jun 19. No abstract available.

29.
30.

Comparing center-specific cumulative incidence functions.

Fan L, Schaubel DE.

Lifetime Data Anal. 2016 Jan;22(1):17-37. doi: 10.1007/s10985-015-9324-1. Epub 2015 Mar 20.

31.

A Reassessment of the Survival Advantage of Simultaneous Kidney-Pancreas Versus Kidney-Alone Transplantation.

Sung RS, Zhang M, Schaubel DE, Shu X, Magee JC.

Transplantation. 2015 Sep;99(9):1900-6. doi: 10.1097/TP.0000000000000663.

32.

Serum sodium and survival benefit of liver transplantation.

Sharma P, Schaubel DE, Goodrich NP, Merion RM.

Liver Transpl. 2015 Mar;21(3):308-13. doi: 10.1002/lt.24063. Epub 2015 Feb 10.

33.
34.

Methods for Estimating Center Effects on Recurrent Events.

Liu D, Kalbfleisch JD, Schaubel DE.

Stat Biosci. 2014 May 1;6(1):19-37.

35.

A weighted cumulative sum (WCUSUM) to monitor medical outcomes with dependent censoring.

Sun RJ, Kalbfleisch JD, Schaubel DE.

Stat Med. 2014 Aug 15;33(18):3114-29. doi: 10.1002/sim.6139. Epub 2014 Mar 13.

36.

Semiparametric methods for center effect measures based on the ratio of survival functions.

He K, Schaubel DE.

Lifetime Data Anal. 2014 Oct;20(4):619-44. doi: 10.1007/s10985-014-9293-9. Epub 2014 Feb 28.

37.

Methods for comparing center-specific survival outcomes using direct standardization.

He K, Schaubel DE.

Stat Med. 2014 May 30;33(12):2048-61. doi: 10.1002/sim.6089. Epub 2014 Jan 17.

38.

Disparities in liver transplantation: the association between donor quality and recipient race/ethnicity and sex.

Mathur AK, Schaubel DE, Zhang H, Guidinger MK, Merion RM.

Transplantation. 2014 Apr 27;97(8):862-9. doi: 10.1097/01.tp.0000438634.44461.67.

39.

Patient-specific prediction of ESRD after liver transplantation.

Sharma P, Goodrich NP, Schaubel DE, Guidinger MK, Merion RM.

J Am Soc Nephrol. 2013 Dec;24(12):2045-52. doi: 10.1681/ASN.2013040436. Epub 2013 Sep 12.

40.

Comparison of methods for estimating the effect of salvage therapy in prostate cancer when treatment is given by indication.

Taylor JM, Shen J, Kennedy EH, Wang L, Schaubel DE.

Stat Med. 2014 Jan 30;33(2):257-74. doi: 10.1002/sim.5890. Epub 2013 Jul 3.

41.

Proportional hazards regression in the presence of missing study eligibility information.

Pan Q, Schaubel DE.

Lifetime Data Anal. 2014 Jul;20(3):424-43. doi: 10.1007/s10985-013-9273-5. Epub 2013 Jun 22.

42.

An estimating function approach to the analysis of recurrent and terminal events.

Kalbfleisch JD, Schaubel DE, Ye Y, Gong Q.

Biometrics. 2013 Jun;69(2):366-74. doi: 10.1111/biom.12025. Epub 2013 May 7.

43.

Partly conditional estimation of the effect of a time-dependent factor in the presence of dependent censoring.

Gong Q, Schaubel DE.

Biometrics. 2013 Jun;69(2):338-47. doi: 10.1111/biom.12023. Epub 2013 May 2.

44.

Short-term pretransplant renal replacement therapy and renal nonrecovery after liver transplantation alone.

Sharma P, Goodrich NP, Zhang M, Guidinger MK, Schaubel DE, Merion RM.

Clin J Am Soc Nephrol. 2013 Jul;8(7):1135-42. doi: 10.2215/CJN.09600912. Epub 2013 Feb 28.

45.

Choice of reference in the evaluation of the day-of-week effect on mortality on hemodialysis.

Zhang H, Schaubel DE, Kalbfleisch JD, Robinson BM, Pisoni RL, Port FK, Saran R.

Kidney Int. 2012 Dec;82(12):1339-40; author reply 1340. doi: 10.1038/ki.2012.342. No abstract available.

46.

Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score.

Sharma P, Schaubel DE, Messersmith EE, Guidinger MK, Merion RM.

Liver Transpl. 2012 Dec;18(12):1456-63. doi: 10.1002/lt.23548.

47.

Contrasting treatment-specific survival using double-robust estimators.

Zhang M, Schaubel DE.

Stat Med. 2012 Dec 30;31(30):4255-68. doi: 10.1002/sim.5511. Epub 2012 Jul 16.

48.

Analytic morphomics, core muscle size, and surgical outcomes.

Englesbe MJ, Lee JS, He K, Fan L, Schaubel DE, Sheetz KH, Harbaugh CM, Holcombe SA, Campbell DA Jr, Sonnenday CJ, Wang SC.

Ann Surg. 2012 Aug;256(2):255-61. doi: 10.1097/SLA.0b013e31826028b1.

PMID:
22791101
49.

Semiparametric Transformation Rate Model for Recurrent Event Data.

Zeng D, Schaubel DE, Cai J.

Stat Biosci. 2011 Dec 1;3(2):187-207.

50.

Double-robust semiparametric estimator for differences in restricted mean lifetimes in observational studies.

Zhang M, Schaubel DE.

Biometrics. 2012 Dec;68(4):999-1009. doi: 10.1111/j.1541-0420.2012.01759.x. Epub 2012 Apr 4.

Supplemental Content

Loading ...
Support Center